5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Sell
38
BIO Quote, Financials, Valuation and Earnings
Last price:
$241.56
Seasonality move
:
2.45%
Day range:
$229.84 - $236.15
52-week range:
$215.38 - $387.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.57x
P/B ratio:
0.95x
Volume:
280.6K
Avg. volume:
376.3K
1-year change:
-16.92%
Market cap:
$6.3B
Revenue:
$2.6B
EPS (TTM):
-$76.20
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.9B | $2.8B | $2.7B | $2.6B | |
| Revenue Growth (YoY) | 10.12% | 14.81% | -4.12% | -4.68% | -3.92% | |
| Cost of Revenues | $1.1B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Gross Profit | $1.4B | $1.6B | $1.6B | $1.4B | $1.4B | |
| Gross Profit Margin | 56.49% | 56.05% | 55.93% | 53.42% | 53.73% | |
| R&D Expenses | $217.8M | $260.6M | $256.9M | $247.4M | $295.9M | |
| Selling, General & Admin | $798.8M | $877.1M | $827.8M | $841.7M | $814M | |
| Other Inc / (Exp) | $4.5B | $4.9B | -$5.2B | -$1.2B | -$2.6B | |
| Operating Expenses | $1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Operating Income | $421.3M | $500.3M | $475.1M | $337.8M | $269M | |
| Net Interest Expenses | $3.7M | -- | -- | -- | $48.9M | |
| EBT. Incl. Unusual Items | $4.9B | $5.4B | -$4.7B | -$850.1M | -$2.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1B | $1.2B | -$1.1B | -$212.8M | -$498.3M | |
| Net Income to Company | $3.8B | $4.3B | -$3.6B | -$637.3M | -$1.8B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.8B | $4.3B | -$3.6B | -$637.3M | -$1.8B | |
| Basic EPS (Cont. Ops) | $128.13 | $142.61 | -$121.79 | -$21.82 | -$65.36 | |
| Diluted EPS (Cont. Ops) | $126.47 | $140.83 | -$121.79 | -$21.82 | -$65.36 | |
| Weighted Average Basic Share | $29.8M | $29.8M | $29.8M | $29.2M | $28.2M | |
| Weighted Average Diluted Share | $30.2M | $30.2M | $29.8M | $29.2M | $28.2M | |
| EBITDA | $5.1B | $5.6B | -$4.5B | -$654.8M | -$2.1B | |
| EBIT | $4.9B | $5.5B | -$4.7B | -$800.7M | -$2.3B | |
| Revenue (Reported) | $2.5B | $2.9B | $2.8B | $2.7B | $2.6B | |
| Operating Income (Reported) | $421.3M | $500.3M | $475.1M | $337.8M | $269M | |
| Operating Income (Adjusted) | $4.9B | $5.5B | -$4.7B | -$800.7M | -$2.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $726.8M | $700.1M | $676.8M | $610.8M | $585.4M | |
| Revenue Growth (YoY) | 27.14% | -3.68% | -3.32% | -9.76% | -4.16% | |
| Cost of Revenues | $326.2M | $297.4M | $314.4M | $284.9M | $279.4M | |
| Gross Profit | $400.6M | $402.6M | $362.4M | $325.9M | $306M | |
| Gross Profit Margin | 55.12% | 57.51% | 53.55% | 53.36% | 52.27% | |
| R&D Expenses | $73.9M | $59.5M | $75M | $66.4M | $73.5M | |
| Selling, General & Admin | $225.9M | $196.7M | $225.6M | $214.9M | $208.8M | |
| Other Inc / (Exp) | $1.2B | -$4.5B | -$15.1M | $424.8M | $35.5M | |
| Operating Expenses | $299.8M | $256.2M | $300.5M | $281.3M | $282.3M | |
| Operating Income | $100.9M | $146.4M | $61.9M | $44.6M | $23.7M | |
| Net Interest Expenses | $398K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.3B | -$4.4B | $84.8M | $491.1M | $83.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $319.8M | -$1B | $15.9M | $107.2M | $19.4M | |
| Net Income to Company | $977.4M | -$3.4B | $69M | $383.9M | $64M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $977.4M | -$3.4B | $69M | $383.9M | $64M | |
| Basic EPS (Cont. Ops) | $32.77 | -$112.50 | $2.33 | $13.46 | $2.29 | |
| Diluted EPS (Cont. Ops) | $32.38 | -$112.50 | $2.32 | $13.45 | $2.29 | |
| Weighted Average Basic Share | $29.8M | $29.9M | $29.6M | $28.5M | $27.9M | |
| Weighted Average Diluted Share | $30.2M | $29.9M | $29.7M | $28.5M | $28M | |
| EBITDA | $1.3B | -$4.3B | $132.8M | $540.5M | $133.5M | |
| EBIT | $1.3B | -$4.4B | $97.2M | $503.4M | $95.4M | |
| Revenue (Reported) | $726.8M | $700.1M | $676.8M | $610.8M | $585.4M | |
| Operating Income (Reported) | $100.9M | $146.4M | $61.9M | $44.6M | $23.7M | |
| Operating Income (Adjusted) | $1.3B | -$4.4B | $97.2M | $503.4M | $95.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.9B | $2.8B | $2.6B | $2.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.2B | $1.3B | $1.3B | $1.2B | $1.2B | |
| Gross Profit | $1.5B | $1.6B | $1.5B | $1.4B | $1.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $242.4M | $246.3M | $272.3M | $238.8M | $303M | |
| Selling, General & Admin | $831M | $848M | $856.7M | $831M | $807.9M | |
| Other Inc / (Exp) | $4.9B | -$789.6M | -$671.8M | -$799.6M | -$3B | |
| Operating Expenses | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Operating Income | $447.8M | $545.9M | $390.6M | $320.5M | $248M | |
| Net Interest Expenses | $1.2M | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $5.3B | -$216.2M | -$251.3M | -$443.8M | -$2.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.2B | -$125.7M | -$60.1M | -$121.5M | -$586.1M | |
| Net Income to Company | $4.1B | -$90.4M | -$191.2M | -$322.4M | -$2.2B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $4.1B | -$90.5M | -$191.2M | -$322.4M | -$2.2B | |
| Basic EPS (Cont. Ops) | $137.73 | -$2.63 | -$6.31 | -$10.33 | -$76.17 | |
| Diluted EPS (Cont. Ops) | $135.98 | -$4.81 | -$6.43 | -$10.36 | -$76.20 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $5.5B | -$72.4M | -$65.5M | -$247.1M | -$2.5B | |
| EBIT | $5.3B | -$210.7M | -$205M | -$394.5M | -$2.7B | |
| Revenue (Reported) | $2.7B | $2.9B | $2.8B | $2.6B | $2.5B | |
| Operating Income (Reported) | $447.8M | $545.9M | $390.6M | $320.5M | $248M | |
| Operating Income (Adjusted) | $5.3B | -$210.7M | -$205M | -$394.5M | -$2.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $726.8M | $700.1M | $676.8M | $610.8M | $585.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $326.2M | $297.4M | $314.4M | $284.9M | $279.4M | |
| Gross Profit | $400.6M | $402.6M | $362.4M | $325.9M | $306M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $73.9M | $59.5M | $75M | $66.4M | $73.5M | |
| Selling, General & Admin | $225.9M | $196.7M | $225.6M | $214.9M | $208.8M | |
| Other Inc / (Exp) | $1.2B | -$4.5B | -$15.1M | $424.8M | $35.5M | |
| Operating Expenses | $299.8M | $256.2M | $300.5M | $281.3M | $282.3M | |
| Operating Income | $100.9M | $146.4M | $61.9M | $44.6M | $23.7M | |
| Net Interest Expenses | $398K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.3B | -$4.4B | $84.8M | $491.1M | $83.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $319.8M | -$1B | $15.9M | $107.2M | $19.4M | |
| Net Income to Company | $977.4M | -$3.4B | $69M | $383.9M | $64M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $977.4M | -$3.4B | $69M | $383.9M | $64M | |
| Basic EPS (Cont. Ops) | $32.77 | -$112.50 | $2.33 | $13.46 | $2.29 | |
| Diluted EPS (Cont. Ops) | $32.38 | -$112.50 | $2.32 | $13.45 | $2.29 | |
| Weighted Average Basic Share | $29.8M | $29.9M | $29.6M | $28.5M | $27.9M | |
| Weighted Average Diluted Share | $30.2M | $29.9M | $29.7M | $28.5M | $28M | |
| EBITDA | $1.3B | -$4.3B | $132.8M | $540.5M | $133.5M | |
| EBIT | $1.3B | -$4.4B | $97.2M | $503.4M | $95.4M | |
| Revenue (Reported) | $726.8M | $700.1M | $676.8M | $610.8M | $585.4M | |
| Operating Income (Reported) | $100.9M | $146.4M | $61.9M | $44.6M | $23.7M | |
| Operating Income (Adjusted) | $1.3B | -$4.4B | $97.2M | $503.4M | $95.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $662.2M | $470.8M | $434.2M | $403.8M | $488.1M | |
| Short Term Investments | $328.9M | $399.1M | $1.4B | $1.2B | $1.2B | |
| Accounts Receivable, Net | $419.4M | $423.5M | $494.6M | $489M | $452.5M | |
| Inventory | $622.3M | $572.2M | $719.3M | $780.5M | $760M | |
| Prepaid Expenses | $90.6M | $109.1M | $124.2M | $140M | $122.6M | |
| Other Current Assets | $10.9M | $10.1M | $23.6M | $26.1M | $30.7M | |
| Total Current Assets | $2.1B | $2B | $3.2B | $3B | $3B | |
| Property Plant And Equipment | $693.5M | $716.4M | $679.6M | $723.7M | $688.6M | |
| Long-Term Investments | $9.6B | $14.4B | $8.8B | $7.7B | $4.8B | |
| Goodwill | $291.9M | $347.3M | $406.5M | $413.6M | $410.5M | |
| Other Intangibles | $199.5M | $253.9M | $332.1M | $320.5M | $293.6M | |
| Other Long-Term Assets | $86.7M | $104.2M | $94.6M | $94.9M | $101.9M | |
| Total Assets | $13B | $17.8B | $13.5B | $12.3B | $9.4B | |
| Accounts Payable | $139.5M | $141.9M | $135M | $144.6M | $122.3M | |
| Accrued Expenses | $222.9M | $277M | $194.8M | $139.9M | $124.2M | |
| Current Portion Of Long-Term Debt | $1.3M | $489K | $465K | $500K | $1.2M | |
| Current Portion Of Capital Lease Obligations | $37M | $36.4M | $36.3M | $40.4M | $41.7M | |
| Other Current Liabilities | $131.1M | $127.9M | $169.6M | $161.6M | $147.2M | |
| Total Current Liabilities | $631.5M | $680.9M | $568.7M | $522.8M | $467.8M | |
| Long-Term Debt | $1.3M | $10.5M | $1.2B | $1.2B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.1B | $4.1B | $3.9B | $3.6B | $2.8B | |
| Common Stock | $3K | $3K | $3K | -- | -- | |
| Other Common Equity Adj | $282.5M | -$175.6M | -$466.8M | -$336M | -$538.2M | |
| Common Equity | $9.9B | $13.7B | $9.6B | $8.7B | $6.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $9.9B | $13.7B | $9.6B | $8.7B | $6.6B | |
| Total Liabilities and Equity | $13B | $17.8B | $13.5B | $12.3B | $9.4B | |
| Cash and Short Terms | $991.1M | $869.9M | $1.8B | $1.6B | $1.7B | |
| Total Debt | $2.6M | $11M | $1.2B | $1.2B | $1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $673.5M | $802.3M | $464.1M | $433.3M | $521.4M | |
| Short Term Investments | $346.4M | $1.3B | $1.4B | $1.2B | $1.1B | |
| Accounts Receivable, Net | $408.1M | $464.1M | $498.3M | $444.8M | $424.7M | |
| Inventory | $605.2M | $605.5M | $752.9M | $783.4M | $790.1M | |
| Prepaid Expenses | $110.3M | $126.7M | $120.8M | $142.7M | $125.4M | |
| Other Current Assets | $26.3M | $28.1M | $48.2M | $38.8M | $36M | |
| Total Current Assets | $2.2B | $3.3B | $3.3B | $3.1B | $3B | |
| Property Plant And Equipment | $678.9M | $684.2M | $680.6M | $711.3M | $681.7M | |
| Long-Term Investments | $10.5B | $9.7B | $8.9B | $8B | $5B | |
| Goodwill | $291.9M | $345.7M | $407.8M | $412.8M | $414.6M | |
| Other Intangibles | $191.8M | $247.1M | $327.8M | $313.6M | $296.1M | |
| Other Long-Term Assets | $92.2M | $103.9M | $95.5M | $92.9M | $103.7M | |
| Total Assets | $13.9B | $14.4B | $13.7B | $12.6B | $9.5B | |
| Accounts Payable | $138.5M | $160.7M | $161M | $102.8M | $137.9M | |
| Accrued Expenses | $174.9M | $184.5M | $173.9M | $146.5M | $157.4M | |
| Current Portion Of Long-Term Debt | $1.2M | -- | $519K | -- | $1.2M | |
| Current Portion Of Capital Lease Obligations | $39.7M | $37.2M | $36.1M | $40.5M | $41.3M | |
| Other Current Liabilities | $166.5M | $211.6M | $167.2M | $142.4M | $131.7M | |
| Total Current Liabilities | $609.9M | $648.3M | $589.6M | $466.2M | $506.6M | |
| Long-Term Debt | -- | $1.2B | $1.2B | $1.2B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.3B | $4.2B | $3.9B | $3.6B | $2.8B | |
| Common Stock | $3K | $3K | $3K | $3K | -- | |
| Other Common Equity Adj | $68.4M | -$307.9M | -$408.4M | -$426M | -$409.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $10.6B | $10.2B | $9.8B | $9.1B | $6.7B | |
| Total Liabilities and Equity | $13.9B | $14.4B | $13.7B | $12.6B | $9.5B | |
| Cash and Short Terms | $1B | $2.1B | $1.9B | $1.6B | $1.7B | |
| Total Debt | $1.2M | $1.2B | $1.2B | $1.2B | $1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.8B | $4.3B | -$3.6B | -$637.3M | -$1.8B | |
| Depreciation & Amoritzation | $138.6M | $137.6M | $137.3M | $145.9M | $151.6M | |
| Stock-Based Compensation | $41.6M | $51.2M | $60.9M | $61.3M | $62.3M | |
| Change in Accounts Receivable | -$15M | -$20.4M | -$87.4M | $11.4M | $16.2M | |
| Change in Inventories | -$52.1M | $46.1M | -$158.8M | -$46.3M | $8.5M | |
| Cash From Operations | $585M | $669.5M | $194.4M | $374.9M | $455.2M | |
| Capital Expenditures | $108.6M | $133.7M | $114.3M | $156.7M | $189M | |
| Cash Acquisitions | -$84.4M | -$125.5M | -$99.3M | $2.5M | -- | |
| Cash From Investing | -$69.9M | -$797.4M | -$1.2B | $20.2M | -$160.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $1.2B | -- | -- | |
| Long-Term Debt Repaid | -$426.9M | -$3M | -$500K | -$500K | -$400K | |
| Repurchase of Common Stock | -$100M | -$50M | -$215.7M | -$428.7M | -$203.6M | |
| Other Financing Activities | -$16.3M | -$23M | -$14M | -$14.9M | -$34M | |
| Cash From Financing | -$523M | -$55.4M | $973.6M | -$425.6M | -$218.8M | |
| Beginning Cash (CF) | $662.7M | $667.1M | $471.1M | $434.5M | $404.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$8M | -$183.3M | -$39.6M | -$30.5M | $76.2M | |
| Ending Cash (CF) | $667.1M | $471.1M | $434.5M | $404.4M | $489.8M | |
| Levered Free Cash Flow | $476.4M | $535.7M | $80.1M | $218.2M | $266.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $977.4M | -$3.4B | $69M | $383.9M | $64M | |
| Depreciation & Amoritzation | $32.7M | $33.4M | $35.6M | $37.1M | $38.1M | |
| Stock-Based Compensation | $11.7M | $13.5M | $16.6M | $15.3M | $15.3M | |
| Change in Accounts Receivable | $1.3M | -$46.8M | -$1.4M | $37.4M | $37.2M | |
| Change in Inventories | $5.8M | -$35.5M | -$30.1M | -$8.8M | -$17.9M | |
| Cash From Operations | $113.6M | $50.5M | $98.1M | $69.8M | $129.9M | |
| Capital Expenditures | $19.5M | $33.1M | $35.7M | $40.2M | $34.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$48.3M | -$916.1M | -$70.5M | -$43.1M | $2.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1.2B | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.4M | -$104K | -$115K | -$200K | -$100K | |
| Repurchase of Common Stock | -$50M | -- | -- | -$4.7M | -$101.9M | |
| Other Financing Activities | -- | -- | -- | -$600K | -- | |
| Cash From Financing | -$47.3M | $1.2B | $4.3M | -- | -$97.7M | |
| Beginning Cash (CF) | $667.1M | $471.1M | $434.5M | $404.4M | $489.8M | |
| Foreign Exchange Rate Adjustment | -$7.3M | $6.9M | -$2M | $2.7M | -$1.8M | |
| Additions / Reductions | $17.9M | $324.6M | $32M | $26.7M | $35.1M | |
| Ending Cash (CF) | $677.7M | $802.7M | $464.5M | $433.8M | $523.1M | |
| Levered Free Cash Flow | $94.1M | $17.4M | $62.4M | $29.6M | $95.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.1B | -$90.4M | -$191.2M | -$322.4M | -$2.2B | |
| Depreciation & Amoritzation | $137.7M | $138.3M | $139.5M | $147.4M | $152.6M | |
| Stock-Based Compensation | $43.6M | $53M | $64M | $60M | $62.3M | |
| Change in Accounts Receivable | -$15.9M | -$68.5M | -$42M | $50.2M | $16M | |
| Change in Inventories | -$32.6M | $4.8M | -$153.4M | -$25M | -$600K | |
| Cash From Operations | $635.8M | $606.3M | $242M | $346.6M | $515.3M | |
| Capital Expenditures | $106.4M | $147.3M | $116.9M | $161.2M | $183.2M | |
| Cash Acquisitions | -$84.4M | -$125.5M | -$99.3M | -- | -- | |
| Cash From Investing | -$105.8M | -$1.7B | -$361.9M | $47.6M | -$114.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.2B | -- | -- | -- | |
| Long-Term Debt Repaid | -$426.9M | -$1.7M | -$511K | -$585K | -$300K | |
| Repurchase of Common Stock | -$50M | -- | -$215.7M | -$433.4M | -$300.8M | |
| Other Financing Activities | -- | -- | -- | -$15.5M | -- | |
| Cash From Financing | -$471.8M | $1.2B | -$212.4M | -$429.9M | -$316.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $58.2M | $123.4M | -$332.3M | -$35.8M | $84.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $529.4M | $459.1M | $125.1M | $185.4M | $332.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $977.4M | -$3.4B | $69M | $383.9M | $64M | |
| Depreciation & Amoritzation | $32.7M | $33.4M | $35.6M | $37.1M | $38.1M | |
| Stock-Based Compensation | $11.7M | $13.5M | $16.6M | $15.3M | $15.3M | |
| Change in Accounts Receivable | $1.3M | -$46.8M | -$1.4M | $37.4M | $37.2M | |
| Change in Inventories | $5.8M | -$35.5M | -$30.1M | -$8.8M | -$17.9M | |
| Cash From Operations | $113.6M | $50.5M | $98.1M | $69.8M | $129.9M | |
| Capital Expenditures | $19.5M | $33.1M | $35.7M | $40.2M | $34.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$48.3M | -$916.1M | -$70.5M | -$43.1M | $2.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1.2B | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.4M | -$104K | -$115K | -$200K | -$100K | |
| Repurchase of Common Stock | -$50M | -- | -- | -$4.7M | -$101.9M | |
| Other Financing Activities | -- | -- | -- | -$600K | -- | |
| Cash From Financing | -$47.3M | $1.2B | $4.3M | -- | -$97.7M | |
| Beginning Cash (CF) | $667.1M | $471.1M | $434.5M | $404.4M | $489.8M | |
| Foreign Exchange Rate Adjustment | -$7.3M | $6.9M | -$2M | $2.7M | -$1.8M | |
| Additions / Reductions | $17.9M | $324.6M | $32M | $26.7M | $35.1M | |
| Ending Cash (CF) | $677.7M | $802.7M | $464.5M | $433.8M | $523.1M | |
| Levered Free Cash Flow | $94.1M | $17.4M | $62.4M | $29.6M | $95.5M | |
Get BIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BIO
Sector
P/E ratio
--
23.85x
PEG ratio
0.00x
0.00x
P/B ratio
0.95x
1.64x
Price / LTM sales
2.57x
1.58x
Growth Metrics
BIO
Sector
Revenue growth
-4.16%
5.51%
Earnings growth
-82.97%
8.33%
Revenue (5-year growth)
2.11%
8.27%
Earnings forecast
$1.78
-$0.20
Profitability
BIO
Sector
Profitability FY 2024
$1.4B
$54M
Return on invested capital
-25.43%
-14.46%
Return on assets
-20.89%
-11.84%
Return on equity
-29.59%
-17.25%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Jul
31
Balance Sheet
BIO
Sector
Total cash
$1.7B
$40.4M
Short term investments
$1.2B
$34.9M
Total assets
$9.4B
$120.5M
Long term debt
$1.2B
$9.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.
Buy
92
TPB alert for May 8
Turning Point Brands [TPB] is down 6.67% over the past day.
Buy
74
LIVN alert for May 8
LivaNova PLC [LIVN] is up 1.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
